Literature DB >> 10824125

Physicochemical characteristics of triacyl lipid A partial structure OM-174 in relation to biological activity.

K Brandenburg1, B Lindner, A Schromm, M H Koch, J Bauer, A Merkli, C Zbaeren, J G Davies, U Seydel.   

Abstract

The triacylated lipid A partial structure OM-174 was characterized in detail using a variety of physical and biological techniques. OM-174 aggregates adopt the micellar HI structure. The temperature (Tc) of the gel to liquid-crystalline phase transition of the hydrocarbon chains is 0 degrees C, from which high fluidity of the acyl chains at 37 degrees C can be deduced. The molecular area of a single OM-174 molecule at a surface pressure of 30 mN x m-1 is 0.78 +/- 0.04 nm2. Conformational analyses, using IR spectroscopy, of the behavior of the various functional groups of OM-174 as compared with hexa-acyl lipid A suggest altered hydration of the phosphate charges and unusually strong hydration of the ester groups, which is probably related to the high accessibility of these groups to water in the micellar aggregate structure. OM-174 was shown to intercalate into a phospholipid membrane corresponding to the macrophage membrane within seconds in the presence, and within minutes to hours in the absence, of LPS-binding protein. In the Limulus amebocyte lysate assay, the triacyl lipid A is more than 105-fold less active than hexa-acyl lipid A, but only 10-fold less active in inducing IL-6 in human mononuclear cells, and equally active in inducing NO production in murine macrophages. These findings are used to explain the mechanism of the lipid A-induced cell activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10824125     DOI: 10.1046/j.1432-1327.2000.01370.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.

Authors:  Irène Dunn-Siegrist; Pierre Tissières; Geneviève Drifte; Jacques Bauer; Stéphane Moutel; Jérôme Pugin
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 2.  Progress in the synthesis and biological evaluation of lipid A and its derivatives.

Authors:  Jian Gao; Zhongwu Guo
Journal:  Med Res Rev       Date:  2017-06-16       Impact factor: 12.944

Review 3.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.

Authors:  L Chatenoud; S You; H Okada; C Kuhn; B Michaud; J-F Bach
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

4.  Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes.

Authors:  Leslie E Walker; Lo Vang; Xuefei Shen; Brian D Livingston; Penny Post; Alessandro Sette; C Steven Godin; Mark J Newman
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

5.  Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.

Authors:  Jesús Arenas; Harry van Dijken; Betsy Kuipers; Hendrik Jan Hamstra; Jan Tommassen; Peter van der Ley
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

6.  Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

7.  Self-Organisation, Thermotropic and Lyotropic Properties of Glycolipids Related to their Biological Implications.

Authors:  Patrick Garidel; Yani Kaconis; Lena Heinbockel; Matthias Wulf; Sven Gerber; Ariane Munk; Volkmar Vill; Klaus Brandenburg
Journal:  Open Biochem J       Date:  2015-08-31

8.  Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially regulates their synergistic and inhibitory receptor crosstalk.

Authors:  Wenqian Li; Miao Li; Stephen M Anthony; Yan Yu
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

Review 9.  Trial Watch: Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-06-10       Impact factor: 8.110

10.  Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-O-acylated lipooligosaccharide.

Authors:  Ji Eun Han; Seo Ri Wui; Kwang Sung Kim; Yang Je Cho; Wan Je Cho; Na Gyong Lee
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.